Funding
Dr. Scarisbrick's Neuroregeneration and Neurorehabilitation Laboratory at Mayo Clinic receives funding from a variety of sources.
Grants
INVESTIGATOR & ROLE
|
GRANT TITLE
|
FUNDING SOURCE
|
DURATION
|
| Isobel A. Scarisbrick, Ph.D., coprincipal investigator |
University of Wisconsin Eau Claire — Mayo Clinic Regenerative Neuroscience Scholars Program (ReNS) |
National Institute of Neurological Disorders and Stroke (NINDS) R25 grant |
07/2024 to 06/2028 |
| Isobel A. Scarisbrick, Ph.D., principal investigator |
Blocking the Thrombin Receptor to Improve Neural Stem Cell-Mediated CNS Regeneration |
Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program |
09/2023 to 08/2025 |
| Isobel A. Scarisbrick, Ph.D., principal investigator |
Targeting Protease-Activated Receptor 1 for Repair of the Injured Spinal Cord |
National Institutes of Health (NIH), NINDS Clinical Neuroplasticity and Neurotransmitters Study Section (CNNT)
R01 NS120877-A0 |
09/2021 to 08/2025 |
| Isobel A. Scarisbrick, Ph.D., mentor |
Mechanisms of Kallikrein 6 in Myelin Plasticity, Motor Learning and Fear Memory |
NIH, NINDS F31 NS129252 |
07/2023 to 06/2025 |
| Isobel A. Scarisbrick, Ph.D., principal investigator |
PAR1 Knockout Neural Stem Cells for In Vivo Myelin Regeneration |
Mayo Clinic's Center for Regenerative Biotherapeutics: Charles B. and Ann L. Johnson Fund for Regenerative Medicine, Neuro-Regenerative Medicine Initiative |
08/2023 to 09/2024 |
| Isobel A. Scarisbrick, Ph.D., principal investigator |
Protease-Activated Receptor Targets for Myelin Regeneration — Competitive Renewal |
National Multiple Sclerosis Society Research Grant RG-1901-33209 |
10/2019 to 09/2024 |